Daewon Pharm (003220)

Seoul
16,350.00
+150.00(+0.93%)
  • Volume:
    41,942
  • Bid/Ask:
    16,350.00/16,400.00
  • Day's Range:
    16,200.00 - 16,550.00

003220 Overview

Prev. Close
16,200
Day's Range
16,200 - 16,550
Revenue
308.5B
Open
16,350
52 wk Range
14,381 - 30,857
EPS
845.58
Volume
41,942
Market Cap
343.84B
Dividend (Yield)
152.38 (0.94%)
Average Vol. (3m)
77,161
P/E Ratio
19.16
Beta
0.65
1-Year Change
12.6%
Shares Outstanding
20,574,668
Next Earnings Date
May 19, 2021
What is your sentiment on Daewon Pharm?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellStrong SellSell
Technical IndicatorsBuyNeutralStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellStrong Sell

Daewon Pharm Company Profile

Daewon Pharm Company Profile

Employees
738

Daewon Pharmaceutical Co., Ltd. is a Korea-based company mainly engaged in the manufacture of pharmaceutical products. The Company’s products include antipyretics, analgesics, anti-inflammatory drugs, respiratory drugs, gastrointestinal drugs, antimicrobial drugs, cardiovascular drugs, metabolic drugs, psychoneurotic drugs, neuromuscular drugs, endocrine drugs and others. The Company also produces multivitamins and health foods. The Company distributes its products within domestic market and overseas markets, including Vietnam, Myanmar, Southeast Asia, the Middle East and others.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.